Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Johnson & Johnson Stock a Buy?

TheMotleyFool

0 0

Johnson & Johnson (NYSE: JNJ) didn't have a great year in 2019. Sure, the stock was up 13%. However, that wasn't even half the gain that the S&P 500 index delivered last year. J&J was bogged down by opioid-related litigation, more worries that its talc-based products contain asbestos, and anemic growth.

But it's not a good idea to base an opinion about any stock on one problematic year, especially the stock of a company that's been in business for more than 130 years. Is Johnson & Johnson stock a buy now? The answer: It depends.

Image source: Getty Images.

Source Fool.com

Like: 0

JNJ

Teilen